All AbMole products are for research use only, cannot be used for human consumption.
ATB-346 suppresses gastric prostaglandin E(2) synthesis as effectively as naproxen, but produces negligible damage in the stomach and intestine. ATB-346 accelerates healing of pre-existing gastric ulcers. ATB-346 significantly reduces the severity of inflammation (proinflammatory cytokines, apoptosis of neural tissue, and nitrosative stress) that characterizes the secondary effects of SCI.
| Molecular Weight | 365.45 |
| Formula | C21H19NO3S |
| CAS Number | 1226895-20-0 |
| Solubility (25°C) | DMSO ≥ 40 mg/mL |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
| Related COX Products |
|---|
| Firocoxib
Firocoxib is a selective COX-2 inhibitor exhibiting high selectivity to inhibit COX-2. |
| Ampiroxicam
Ampiroxicam is a nonselective cyclooxygenase inhibitor uesd as anti-inflammatory compound. |
| Bufexamac
Bufexamac is a COX inhibitor for IFN-α release with EC50 of 8.9 μM. |
| Carprofen
Carprofen inhibits canine COX2 with IC50 of 0.03 mM. |
| Diclofenac Diethylamine
Diclofenac diethylamine is a nonsteroidal anti-inflammatory compound taken to reduce inflammation and as an analgesic reducing pain in certain conditions. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
